NCT00006350 2019-11-04
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 2 Completed
University of Maryland, Baltimore
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Roger Williams Medical Center